KLK3 and colorectal cancer: Whereas in many cancer types blood-based markers have been developed to screen for disease recurrence, such as carcinoembryonic antigen (CEA) for colorectal cancer and prostate specific antigen (PSA) for prostate cancer [7,8], there are no clinically implemented tumor markers for sarcoma.